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Abstract
Background: Escherichia coli Nissle 1917 (EcN) is a probiotic used in the treatment of intestinal diseases. Although
it is considered safe, EcN is closely related to the uropathogenic E. coli strain CFT073 and contains many of its
predicted virulence elements. Thus, it is relevant to assess whether virulence-associated genes are functional in EcN.
One of these genes encodes the secreted autotransporter toxin (Sat), a member of the serine protease
autotransporters of Enterobacteriaceae (SPATEs) that are secreted following the type V autotransporter pathway. Sat
is highly prevalent in certain E. coli pathogenic groups responsible for urinary and intestinal infections. In these
pathogens Sat promotes cytotoxic effects in several lines of undifferentiated epithelial cells, but not in differentiated
Caco-2 cells.
Results: Here we provide evidence that sat is expressed by EcN during the colonization of mouse intestine. The
EcN protein is secreted as an active serine protease, with its 107 kDa-passenger domain released into the medium
as a soluble protein. Expression of recombinant EcN Sat protein in strain HB101 increases paracellular permeability
to mannitol in polarized Caco-2 monolayers. This effect, also reported for the Sat protein of diffusely adherent E.
coli, is not observed when this protein is expressed in the EcN background. In addition, we show that EcN
supernatants confer protection against Sat-mediated effects on paracellular permeability, thus indicating that other
secreted EcN factors are able to prevent barrier disruption caused by pathogen-related factors. Sat is not required
for intestinal colonization, but the EcNsat::cat mutant outcompetes wild-type EcN in the streptomycin-treated
mouse model. Analysis of the presence of sat in 29 strains of the ECOR collection isolated from stools of healthy
humans shows 34.8 % positives, with high prevalence of strains of the phylogenetic groups D and B2, related with
extra-intestinal infections.
Conclusions: Sat does not act as a virulence factor in EcN. The role of Sat in intestinal pathogenesis relies on other
genetic determinants responsible for the bacterial pathotype.
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Background
Escherichia coli Nissle 1917 (EcN) (serotype O6:K5:H1)
is a Gram-negative probiotic used in the treatment of in-
testinal disorders, especially inflammatory bowel diseases
[1–3]. This strain, originally isolated from a soldier who
survived a severe outbreak of diarrhoea during the First
World War, is a good colonizer of the human gut and
positively affects gastrointestinal homeostasis and micro-
biota balance. EcN modulates the expression of antimicro-
bial peptides, increases secretion of IgA and mucin, and
promotes anti-inflammatory modulation of the immune
response [4]. In addition, this probiotic modulates the in-
testinal epithelial barrier through upregulation and redis-
tribution of tight junction proteins [5–7].
The EcN genome has been sequenced (genome size
5,441,200 bp) and is predicted to contain 5,324 coding
sequences, among which 190 genes are strain-specific
[8, 9]. EcN is furnished with a large repertoire of fitness
factors that promote its competitiveness, which prob-
ably explains its success as a probiotic. Among these
fitness factors there are microcins, iron uptake systems,
adhesins and proteases that contribute to the
colonization of the human gut [10–12]. Genes encoding
these factors are mainly clustered in genomic islands
and some smaller groups. Comparative genomic
hybridization studies and genome sequencing revealed
that the probiotic strain EcN is closely related to the
uropathogenic E. coli strain (UPEC) CFT073 [9, 12].
Even though the two strains use different communica-
tion strategies with the host, their gene profiles are very
similar (differing only in a few hundred genes). EcN
lacks genes encoding defined virulence factors such as
haemolysin and P-fimbrial adhesin, but most of the pre-
dicted CFT073 virulence elements are also present in
the EcN genome. A transcriptomic analysis revealed
that many UPEC virulence-related genes are expressed
in the probiotic EcN [13]. The borderline between viru-
lence and fitness factor is in some cases diffuse, as viru-
lence depends on factors that increase fitness during
colonization of specific host niches. One of these fac-
tors is the secreted autotransporter toxin Sat, encoded
in EcN by a gene located in the genomic island II. Sat
belongs to the subfamily of serine protease autotran-
sporters of Enterobacteriaceae (SPATEs). This family is
composed of extracellular proteases with diverse func-
tions, normally associated with virulence of Gram-
negative pathogens, which are secreted by the type Va
secretion pathway [14, 15]. These proteins display the
typical features of autotransporters: an N-terminal sig-
nal sequence, a passenger domain secreted into the
extracellular medium and a C-terminal β-barrel domain
involved in protein translocation through the outer
membrane. Proteins of the SPATE family have been
classified into two main groups according to their
structure and activity as well as to phylogenetic criteria.
Class I includes proteins with cytotoxic activity and
class II comprises non-cytotoxic proteins with roles in
colonization and immunomodulation [16, 17].
Sat is a class I protease synthesized as a precursor
(142 kDa) and processed at the N-terminal end on its
way to the periplasmic space via the Sec secretion sys-
tem (residues 1–49). This protein is subsequently self-
transported through the outer membrane and undergoes
another proteolytic cleavage which releases the protease
domain (residues 50–1018; 107 kDa) and keeps the C-
terminal domain anchored to the outer membrane (resi-
dues 1019–1295; 31 kDa) [18]. Sat function has been
studied in pathogens, specifically in the UPEC strain
CFT073, and in Afa/Dr difussely adherent E. coli
(DAEC) responsible for urinary tract and intestinal in-
fections. In vitro studies showed that Sat from UPEC
strains displays proteolytic activity on casein, spectrin,
fodrin and coagulation factor V. Mucin, pepsin or IgA
were not degraded by Sat [18–20]. In several cellular
models of kidney, bladder and undifferentiated epithelial
cells Sat promotes cytotoxic effects including vacuoliza-
tion, autophagy and cell detachment [18, 21, 22]. Studies
using subclonfluent HeLa cells exposed to Sat from Afa/
Dr DAEC strains revealed that these cytotoxic effects
are preceded by F-actin cytoskeleton disassembly [22].
Moreover, several reports provide evidence that Sat is in-
ternalized by host cells and localized both in the cytosol
and in nucleus [20, 22]. In differentiated Caco-2 cells,
this toxin induces rearrangements of the tight junctions-
associated proteins ZO-1 and ZO-2 and occludins, lead-
ing to an increase in both fluid dome formation and
paracellular permeability to small molecules like manni-
tol, without altering the monolayer transepithelial elec-
trical resistance (TER). In this model, Sat of DAEC does
not modify the paracellular permeability to fluorescein-
5-sulphonic acid (478 Da), nor does it trigger dissoci-
ation of the F-actin network [23]. No experimental evi-
dence of Sat-mediated proteolysis of tight junction-
proteins has been reported to date. In vivo experiments
carried out with Sat from a DAEC strain isolated from a
child with diarrhea showed that this toxin induces fluid
accumulation and histological effects in rabbit ileon
loops. However, the intensity of the observed effects dis-
played great variation between animals, suggesting that
other host factors may influence the establishment of
diarrheal diseases [24].
As EcN is considered a safe probiotic [4, 25] it is
relevant to test whether virulence-associated genes
are expressed and whether the encoded proteins are
functional. We report here the expression of sat dur-
ing the colonization of the mouse intestine by EcN,
and provide evidence that EcN Sat is a functional
protease. We report that the negative effects of Sat
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on the paracellular permeability of Caco-2 monolayers
in vitro are not seen in the probiotic strain. In
addition, we have performed colonization experiments
using the streptomycin-treated mouse model, as well
as a PCR survey to evaluate prevalence of sat among
the E. coli reference collection (ECOR) strains from
human intestinal origin. Our results indicate that the
putative pathogenic role of Sat in the intestinal tract
depends on the expression of other strain virulence
determinants.
Methods
Bacterial strains and growth conditions
E. coli strains and plasmids used in this study are listed
in Table 1. Bacterial cells were routinely grown at 37 °C
in Luria-Bertani broth (LB). When indicated, cells were
grown in minimal medium (MM) [26] supplemented
with 0.2 % glucose and 0.02 % casamino acids [13] or
DMEM (Dulbecco’s Modified Eagle Medium). Growth
was monitored by measuring the optical density at
600 nm (OD600). Bacterial cells were counted by platting
serial dilutions on LB-plates containing the appropriate
antibiotic. When required, ampicillin (Ap) (100 μg/ml),
chloramphenicol (Cm) (20 μg/ml), streptomycin (Sm)
(100 μg/ml), rifampicin (Rf ) (25 μg/ml) or tetracycline
(Tc) (12.5 μg/ml) was added to the medium. Expression
of β-galactosidase was achieved by addition of 5 mM
isopropyl-β-D-1-thiogalactopyranoside (IPTG) to the
culture medium.
Construction of mutant strains
Rf- or Sm-resistant mutants were obtained by spontaneous
mutation. To construct an EcN isogenic sat mutant, the 3
Kb-fragment encoding the Sat passenger domain was amp-
lified with primers Mut-sat-Fw ACAGGATCCGCAAA
TATTGATATATATCAAATGTATGG) and Mut-sat-
Rev (ACAGAATTCGTTGACCTCAGCAAGGAAG) and
cloned into the EcoRI/BamHI restriction sites of plasmid
pUC18Not (Biomedal). The resulting recombinant plas-
mid was then digested with SwaI (with a single restriction
site in the sat gene) and ligated with a cat cassette that
confers resistance to Cm. This cassette was obtained by
digestion of plasmid pCAT19 [27] with SmaI. The recom-
binant plasmid was then digested with NotI and the frag-
ment sat::cat was cloned into the NotI restriction site of
vector pUTmini-Tn5 Tc (Biomedal). After electroporation
of E. coli S17 (λpir) with this final construct, the introduc-
tion of the sat::cat mutation into the EcN chromosome
was performed by conjugation using as a recipient strain a
Rf-resistant derivative of EcN. Transconjugants having the
Rfr Cmr Tcs Aps phenotypes were selected. Chromosomal
insertion was confirmed by PCR. This insertional inactiva-
tion did not cause polarity on downstream genes as sat is
transcribed as a single unit. Growth rates of the sat mu-
tant strain in LB or DMEM were indistinguishable from
that of the parental EcN strain.
DNA manipulation and site-directed mutagenesis
Bacterial genomic DNA was obtained using the Wizard
Genomic DNA purification kit (Promega), and plasmid
Table 1 Strains and plasmids used in this study
Strain or plasmid Genotype or description Source or reference
E. coli strains
XL1Blue recA1 lac endA1 gyrA96 thi hsdR17 supE44 relA1 (F’ proAB lacIq lacZ ΔM15 Tn10) Stratagene
DH5α F− Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk− mk−) phoA supE44 λ− thi- gyrA96 relA1 Gibco BRL
HB101 F− mcrB mrr hsdS20(rB
− mB
−) recA13 leuB6 ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 rpsL20(SmR) glnV44 λ− ATCC 33694
S17(λpir) Tpr Smr recA thi pro hsdR hsdM+RP4::2-Tc::Mu::Km Tn7 λ Biomedal
Nissle 1917 (EcN) Non-pathogenic probiotic isolate (O6:K5:H1) Ardeypharm
EcNsat::cat Nissle 1917 sat::cat; Cmr This study
E2348/69 Wild type EPEC O127:H6 Smr B.B. Finlay
ECOR collection strains Human stool isolates [43]
Plasmids
pBR322 Vector for cloning, Apr Tcr Biolabs
pSat Gene sat from EcN cloned in pBR322, Apr This study
pSat-S256I Gene sat from EcN encoding the mutated Sat-S256I cloned in pBR322, Apr This study
pCAT19 Source of cat gene, Apr Cmr [26]
pUT mini-Tn5 Tc tnp* gene of Tn5-IS50R inserted in SalI site of pGP704; mini-Tn5 Tc transposable element, Apr Tcr Biomedal
pFU34 Plasmid for transcriptional fusions to the reporter gene gfpmut3.1, Ap
r [28]
pFU34-sat Promoter fusion Φ(sat-gfpmut3.1) in PFU34, Ap
r This study
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DNA was prepared using the Wizard Plus SV Midipreps
DNA purification system (Promega). DNA manipula-
tions were performed essentially as described elsewhere
[28]. DNA fragments were amplified by PCR using E.
coli chromosomal DNA as a template. PCR reactions
were performed with Taq DNA polymerase or pfu DNA
polymerase in standard conditions. DNA sequencing
was carried out with an automated ABI 377 DNA se-
quencer and fluorescent dye termination methods.
The sat gene from EcN was amplified by PCR using
primers pBR-sat-Fw (TACGGATCCGGATCAGGGTTG
GCAATATCG) and pBR-sat-Rev (GCTAATAATGAG
AGCAAGAGCGAT) and cloned into pBR322 between
BamHI and NruI restriction sites. This construct encom-
passes the complete sat coding sequence and the
435 bp-region upstream the ATG start codon. Site-
directed mutagenesis of the Sat catalytic serine residue
(S256) was performed using the Quick change site-
directed mutagenesis kit (Stratagen) following the manu-
facturer’s instructions. The set of primers used to replace
this residue to isoleucine (S256I) were TCGGAGACA
TCGGCTCTGG and CCAGAGCCGATGTCTCCGA.
Construction of sat-gfp promoter fusion and detection of
the reporter protein
Plasmid pFU34-sat (sat-gfp promoter fusion) was con-
structed by amplification of the sat upstream region with
primers Sat-gfp-Fw (GGCGGATCCCGGTCTGAATA
ACGCAGCTAG) and Sat-gfp-Rev (GCACGTGTCGA
CATTCATATATTCTCTCAACTCATTTATTGAATGA
ACA) from EcN genomic DNA and cloned into the
BamHI/SalI sites of plasmid pFU34 [29]. GFP expressed
from EcN cells harboring plasmid PFU34-sat was visual-
ized with a fluorescence microscopy (Leica D1000). For
the analysis of the reporter gene expression under in vitro
conditions, EcN harboring pFU34-sat or pFU34 as a con-
trol was diluted 1:50 in fresh culture medium from over-
night cultures and grown at 37 °C to exponential phase.
Fluorescence emitted by bacterial cells was measured in a
microtiter plate reader (Turner BioSystems Modulus™ II
Microplate). The data obtained from three independent
cultures were given as relative fluorescence units per
OD600 (RLU/OD).
Isolation of secreted proteins
Isolation of secreted proteins was performed as previ-
ously described [30]. Briefly, overnight cultures in LB
were diluted 1:50 in the indicated culture media and in-
cubated at 37 °C. After 8 h of growth (OD600 of 1.0) bac-
teria were collected by centrifugation (5,000 x g, 10 min,
4 °C), and the supernatant was passed through a
0.22 μm-pore-size filter (Millipore). For protease activity
assays, cell-free supernatants were concentrated 500-fold
using Centricon-Plus-70 centrifugal filters (Millipore)
with a molecular weight cut-off of 100 kDa. Protein con-
centration was quantified by the method of Lowry [31].
For Western blot analysis, the proteins in the filtrate
were precipitated by incubation on ice for at least 1 h
with 10 % trichloroacetic acid (TCA). The protein pellet
was washed in 90 % (v/v) ice-cold acetone, air-dried and
suspended in loading buffer before being resolved by so-
dium dodecyl sulphate (SDS)- polyacrylamide gel elec-
trophoresis (PAGE) [32]. Outer membrane vesicles
(OMVs) were isolated from cell-free supernatants as de-
scribed previously [33].
Serine protease and spectrin cleavage assays
Serine protease activity was measured using the p-
nitroanilide substrate assay [20]. Concentrated super-
natant (200 μg protein) was added to a reaction mixture
in 0.1 M morpholinepropanesulfonic acid buffer pH 7.3,
containing 200 mM NaCl, 0.01 mM ZnSO4 and 1 mM
methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide as the
substrate (Sigma-Aldrich). Samples were incubated at
37 °C during 18 h and substrate hydrolysis was moni-
tored at 505 nm. As a control, protease activity was also
assayed after preincubation of samples for 30 min at 37 °
C with 1 mM phenylmethanesulfonyl fluoride (PMSF).
The spectrin cleavage assay was performed as described
elsewhere [20]. Reaction mixtures (20 μl) containing
spectrin (4 μg) (Sigma-Aldrich) and concentrated culture
supernatants were incubated at 37 °C for 24 h. Reaction
products were resolved by SDS-PAGE.
Western blot analysis
For Western blot analysis, protein samples were separated
on 10 % SDS-PAGE and transferred to a HyBond-P
polyvinylidene difluoride membrane by using a Bio-Rad
MiniTransblot apparatus. The membrane was blocked in
PBS-0.05 % Tween-20 and 5 % skimmed milk (blocking
solution) for 1 h at room temperature, and then incubated
with specific antibodies against Sat (1:5,000 dilution in
blocking solution) or with antibodies against β-
galactosidase (Abcam, 1:10,000 dilution) for 16 h at 4 °C.
Anti-Sat polyclonal antibodies (rabbit) were raised against
a conjugated peptide (CKSNNQQTSFDQPDW) of the Sat
passenger domain selected by its antigenicity and surface
exposure features prediction (Genscript). The secondary
antibody was donkey anti-rabbit immunoglobulin horse-
radish peroxidase-linked, diluted 1:15,000 in blocking so-
lution. The protein-antibody complex was visualized by
using the ECL Plus Western blotting detection system
(Amersham Pharmacia Biotech).
Cell culture and infection conditions
HeLa or Caco-2 human colonic adenocarcinoma cells
(ATCC HTB-37) were routinely grown in DMEM
containing 25 mM HEPES, non-essential amino acids,
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100 U/ml of penicillin G and 100 μg/ml of streptomycin.
The medium was supplemented with 10 % (v/v) of heat
inactivated fetal calf serum (FCS) (Gibco BRL, MD, USA).
Cells were incubated at 37 °C in 95 % air / 5 % CO2.
For permeability assays, Caco-2 cells were seeded on
polycarbonate filter supports (0.4 μm, Transwell Corn-
ing) and experiments were performed when confluent
monolayers were fully polarized (15–18 days postconflu-
ence). For infection studies, E. coli cells were grown in
LB overnight at 37 °C; the culture was then diluted 1:50
with fresh medium and grown until the OD600 reached
0.5-1.0. Bacterial cells were collected by centrifugation
and resuspended in DMEM plus 1 % mannose. Two
hours before infection, monolayers of Caco-2 cells were
washed twice in phosphate-buffered saline (PBS;
140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4, pH 7.3) and shifted to serum and antibiotic-
free medium. Caco-2 cells were treated with bacterial
suspensions from the apical side for 3 h at a multiplicity
of infection (MOI) of 100. When indicated, bacterial
concentrated supernatants (200 μg protein) where added
to the apical compartment and incubation was extended
for 3 h.
Transepithelial resistance and permeability measurement
After apical treatment, transepithelial resistance (TER)
was determined with a Millicel-ERS-2 volt-ohmmeter
(Millipore, Bedford, MA). The background of the sup-
porting membrane in filters was subtracted from all
readings before calculations. Results were expressed as
Ω · cm2 monolayer surface area.
Permeability of Caco-2 cell monolayers was deter-
mined by measuring the paracellular passage of [3H]-D-
mannitol from apical to basolateral compartments of the
chamber culture (transwell culture plate inserts; 0.4 μm)
as described elsewhere [34]. Monolayers were washed
with modified Krebs buffer (137 mM NaCl, 5.4 mM KCl,
2.8 mM CaCl2, 1.0 mM MgSO4, 0.3 mM NaH2PO4,
10 mM D-glucose and 10 mM HEPES/Tris, pH 7.4), and
placed in culture wells containing 1.5 and 0.5 ml of
modified Krebs buffer in the basolateral and apical com-
partments, respectively. Apical medium contained
0.2 mCi/mL D-[2-3H]mannitol. Cells were incubated for
15 min at 37 °C. After this time, the basolateral medium
was withdrawn and radioactivity was counted in a scin-
tillation counter (1500 Tri-Carb®, Packard, Downers
Grove, IL). Results were expressed as the percentage of
recovery relative to total radioactivity.
Cytotoxicity assays
EcN Sat cytotoxicity was determined by the 3-(4,5-
dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide
(MTT, Sigma-Aldrich) assay in HeLa cells as described
elsewhere [22]. HeLa cells were seeded into 96-well plates
at 1 x 104 cells/well and grown to 90 % confluency. Before
use, cells were kept overnight with medium containing
0.05 % FCS. Cells were washed twice with PBS and ex-
posed to cell-free culture supernatants in the presence of
fresh media deprived of FCS. At the indicated times, cell
viability was determined the addition of MTT (1 mg/ml
final concentration) followed by 1 hour- incubation at 37 °
C. After solubilization with DMSO the plates were read at
570 nm using a Modulus™ Microplate Photometer
(Turner BiSystems). The results were expressed as per-
centage of cell survival relative to the control (untreated
cells).
Mouse colonization experiments
The streptomycin-treated mouse model, which over-
comes colonization resistance in conventional animals,
was used here to study the competition in gut
colonization between Sm-resistant EcN and the isogenic
EcNsat::cat mutant. The model was adapted from previ-
ous reports [35, 36].
The strains used in this study were spontaneous Smr
mutants, displaying resistance to antibiotic concentra-
tions greater than 2 mg/ml. Both strains EcN Smr and
EcNsat::cat Smr display the same point mutation in rpsL,
resulting in the replacement of the lysine residue at pos-
ition 43 by an isoleucine (AAA has changed to ATA).
Therefore differences in the colonization abilities be-
tween these strains could not be attributed to different
antibiotic resistance degrees. In addition both strains
were resistant to Rf, and EcNsat::cat was resistant to
Cm. Four male CD-1 mice (eight- to ten-weeks old)
were provided with drinking water ad libitum containing
streptomycin sulfate (5 g/l) from 24 hours prior to in-
oculation and over the entire course of the experiment.
Stool samples were proved to be free of Sm-resistant
bacteria before inoculation. Bacterial strains, were grown
overnight in LB, diluted 1:200 and incubated to expo-
nential phase (OD600nm of 0.5). Then, bacterial cells were
collected by centrifugation, washed and resuspended in
PBS to a final concentration of 1x106 CFU/ml. A mixed
suspension (1:1) of strain EcN Smr and the isogenic
sat::cat mutant was prepared to a final concentration of
1x106 CFU/ml, and 0.2 ml of this inoculum was admin-
istrated orogastrically (total number of bacteria 2x105).
At the indicated times over 18 days post-infection, mice
were transferred individually to clean cages and fresh
fecal samples were collected. Feces were weighed, di-
luted and homogenized in sterile PBS. Serial dilutions
were plated on LB-agar containing Sm (100 μg/ml) and
Rf (25 μg/ml). Plates were incubated for 16 to 20 h at
37 °C before quantification of bacteria by plate counts.
To distinguish the two strains, 100 colonies from these
plates were screened onto LB-plates containing Sm
(100 μg/ml) and Cm (20 μg/ml). Results were expressed
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as CFU/g of feces. Three independent colonization ex-
periments were performed, with identical results. Pooled
data from the three independent biological replicates
were presented. Colonization experiments with single
bacterial strains were performed in parallel (n = 4, two
independent biological assays).
To isolate and enumerate bacteria adhered to the
mucus layer, on day 18 post-infection mice were sacri-
ficed. Sections of 4 to 5 cm of the ileum (at 1 cm from
the cecum) and the ascendant colon were removed from
each mouse. Each section of the intestine was washed
three times with PBS to expel the luminal content. Then,
the mucus layer from each fragment of intestine was
scraped, transferred to a sterile tube, weighed and sus-
pended into 1 ml of PBS. Samples were homogenized by
vortexing and plated on LB-agar in the presence of Sm
and Rf. After colony counting, the proportion of each
strain was evaluated by picking 100 colonies on LB-
plates containing Cm as described above. Bacteria were
quantified as CFU/g of mucus.
The colonization experiments for in vivo analysis of
sat expression were performed using essentially the same
mouse model, but adding Ap (2 g/l) instead of Sm to the
drinking water. Briefly, two male CD-1 mice (eight- to
ten-weeks old) were orogastrically inoculated with
0.2 ml of a suspension of EcN cells harboring plasmid
PFU34-sat (2x105CFU) or PFU34 (2x105CFU) as a con-
trol. Five days post-infection, fresh fecal samples, as well
as the mucus layer from the ileon and colon sections,
were collected and processed for quantification of bac-
teria as described above, using in this case LB-plates
containing Ap (100 μg/ml). A drop of each fecal or mu-
cosal suspension was deposited on a slide and visualized
with a fluorescence microscopy (Leica D1000).
Flow cytometry
Human peripheral blood mononuclear cells (PBMCs)
were isolated from fresh buffy coats of healthy human
donors by using HistopaqueR-1077 (Sigma-Aldrich) fol-
lowing the manufacturer instructions. Buffy coats were
provided by the “Banc de Sang i Teixits” of Barcelona
according to the signed agreement with the Institution.
Cells were cultured in DMEM containing gentamicin.
PBMCs were left untreated or incubated with bacterial
concentrated culture supernatants (200 μg total protein)
for 3 h. For antibody staining we followed the manufac-
turer’s recommended protocol. Briefly, PBMCs (1x106
cells/ml; 100 μl) were blocked in PBS + 5 % bovine
serum albumin + 0.1 % NaN3 at 4 °C. After washing,
cells were incubated with the primary antibody anti-
LFA-1 (anti-CD11 + CD18, Abcam) (1:100 dilution in
blocking solution) at 4 °C for 1 h, followed by 30 min-in-
cubation with the secondary antibody Alexa Fluor 488
goat anti-mouse IgG (Life Technologies). Cell viability
was assessed by propidium iodide staining. Data were
analysed using the M X P Cytometry software (Cyt-
ometer FC500) in the Scientific and Technological Cen-
tres of the University of Barcelona (CCiT-UB).
Statistical analysis
Results were presented as mean ± standard error (SE).
Data analysis was performed using SPSS Statistics 20
package software. The statistical significance between
two groups was determined using Student’s -t test. Dif-
ferences between more than two groups were assessed
using one-way ANOVA followed by Tukey’s test. Signifi-
cance was stablished when P < 0.05.
Ethics statement
Experiments with mice were approved by the Animal
Research Ethics Committee of the University of Barce-
lona. PBMCs were isolated from buffy coats provided by
the “Banc de Sang i Teixits” of Barcelona. This transfer
fulfils the regulations approved by the Ethics Committe
of this Institution.
Results and discussion
Sat is autotransported and its passenger domain is
released into the medium in EcN cultures
Previous studies by our group identified Sat-specific pep-
tides in the proteome of OMVs isolated from EcN cul-
tures grown in LB [33]. To examine whether EcN Sat is
secreted, supernatants of LB cultures were processed
and analyzed by Western blot using antibodies anti-Sat
obtained against a peptide of the passenger domain. Cul-
ture was centrifuged and the supernatant filtrated to
eliminate bacteria. An aliquot of this cell-free super-
natant was precipitated with TCA to obtain total se-
creted proteins. The remaining cell-free supernatant was
centrifuged at 150,000 x g for 90 min to isolate OMVs
from soluble secreted proteins. The presence of Sat in
these fractions was analyzed by Western blot. A 107 kDa
protein band was immunodetected in the total super-
natant (Fig. 1, lane 1) and in the OMV free-supernatant
(Fig. 1, lane 2), but not in the OMV fraction (Fig. 1, lane
3). To rule out cytosolic contamination due to cell lysis,
immunoblots were probed with antibodies against the
intracellular protein β-galactosidase. These results indi-
cated that EcN Sat is secreted into the medium as a sol-
uble 107-kDa protein. The C-terminal β-barrel domain
of type V autotransporters remains inserted in the outer
membrane. The absence of a cross-reactive band in the
isolated OMVs is compatible with this secretion path-
way, since the anti-Sat antibodies used do not recognize
protein sequences of the β-barrel domain. The absence
of a cross-reactive band in cellular extracts (Fig. 1, lane
4) is in accordance with the extracellular location of
autotransporters of the SPATE family.
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The Sat protein encoded in the EcN genome displays
serine protease activity
EcN Sat displays the functional motifs of the serine pro-
teases of the SPATE family, including the catalytic triad
formed by H, D and S residues, with the catalytic S256
residue comprised in the conserved GDSGSG motif (po-
sitions 254 to 259 in the protein sequence). To examine
whether EcN Sat displays serine protease activity we
cloned the EcN sat gene in pBR322 (pSat) and con-
structed the Sat mutant S256I by site-directed mutagen-
esis (pSat-S256I). These constructs were transformed
into the E. coli strain HB101 lacking the sat gene, as well
as into the mutant strain EcNsat::cat for comparison.
Protease activity was assayed in concentrated culture su-
pernatants obtained from LB cultures of these trans-
formed cells by measuring hydrolysis of the colorimetric
substrate methoxysuccinyl-Ala-Ala-Pro-Val p-
nitroanilide. We selected this substrate based on pub-
lished results on the activity and specificity of several
proteases of the SPATE family [19]. Supernatants of
strains EcN, HB101 and EcNsat::cat were processed in
parallel. In all samples the presence of Sat was assessed
by Western blot using anti-Sat specific antibodies. Re-
sults are presented in Fig. 2a. Supernatants of EcN wild
type displayed proteolytic activity, which was abolished
by disruption of the sat gene (EcNsat::cat). The proteo-
lytic activity in supernatants of Sat deficient cells trans-
formed with pSat confirmed that the sat gene of the
probiotic strain EcN encodes a functional serine prote-
ase. Consistently, all enzymatically active samples were
completely inhibited by 30 min pre-incubation with the
serine protease inhibitor PMSF. Expression from the re-
combinant plasmid pSat yielded activity levels, which
were between 5–7 times higher than the expression from
the chromosomal gene in EcN strain. In these superna-
tants, there was a correlation between proteolytic activ-
ity values and the amount of Sat protein
immunodetected with specific antibodies. The mutated
Sat protein expressed from the recombinant plasmid
pSat-S256I had negligible protease activity. These data
confirmed Ser256 as the catalytic residue of EcN Sat.
To test whether the EcN toxin was active on known
protein Sat substrates in vitro, concentrated culture su-
pernatants of the recombinant HB101 or EcNsat::cat
strains expressing the wild-type Sat protein were incu-
bated with spectrin. Supernatants of HB101 were proc-
essed in parallel as a control. As shown in Fig. 2b, EcN
Sat is able to degrade spectrin subunits. These results in-
dicated that Sat from the probiotic strain is secreted as
an active serine protease as the toxin from pathogenic E.
coli strains.
Analysis of EcN sat expression during colonization of the
mouse intestine
Since the ecological niche of the commensal strain EcN
is the intestinal tract we sought to analyze whether Sat is
expressed in vivo during intestinal colonization of mice.
To monitor sat expression, the sat promoter of strain
EcN was cloned upstream the reporter gene gfpmut3.1
of plasmid pFU34. This fragment extended 349 bp up-
stream from the ATG start codon. The recombinant
plasmid pFU34-sat was transformed into EcN cells and
expression of green fluorescent protein (GFP) was visu-
alized by fluorescence microscopy. To check the func-
tionality of this construct we first analyzed GFP
expression in cells grown to exponential phase in LB as
well as in DMEM or glucose minimal medium. To
analyze whether expression of sat is temperature-
regulated, cultures were incubated at either 37 °C or 25 °
C. EcN cells harboring the vector pFU34 were processed
in parallel for comparison. Results showed expression
from the sat promoter in all growth conditions tested
(see Additional file 1: Figure S1). Many virulence genes
of bacterial pathogens that infect humans are controlled
by temperature and their expression is induced at 37 °C
[37–39]. Our results rule out temperature regulation of
sat expression in EcN. To quantify the level of GFP ex-
pression in the culture media used, the emitted fluores-
cence was measured using the Turner BioSystems
Modulus™ II Microplate reader. Control cultures of EcN
harboring the vector pFU34 were performed in parallel.
Expression values from the sat promoter were 2.4x104
RFU/OD for cells grown in LB, 2.6x103 RFU/OD in
MM-glucose and 2.9x103 RFU/OD in DMEM. Thus,
maximal expression of sat was achieved in LB. Addition
of compounds present in the gut such as sodium bicar-
bonate (3.7 g/l) or sodium deoxycolate (0.5 mg/ml) to
cultures of EcN (pFU34-sat) in LB or MM-glucose did
not increase the level of GFP expression from the sat
promoter.
Fig. 1 Western blot analysis of Sat secretion by EcN grown in LB.
Several samples collected from an LB culture of EcN were processed
and analysed with anti-Sat antibodies or with anti-LacZ antibodies as
a control of cytosolic contamination: lane 1, TCA-precipitated cell-
free supernatant before isolation of vesicles (total secreted proteins);
lane 2, TCA-precipitated cell-free supernatant after removal of vesi-
cles (soluble secreted proteins); lane 3, isolated OMVs; lane 4, cell ex-
tract (5 μg). IPTG (5 mM) was added to the culture medium to
induce lacZ expression
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The absence of fluorescence background in control
cells harboring the vector pFU34 grown in LB (see
Additional file 1: Figure S1) prompted us to use this
high-copy number fusion system for the analysis of
sat expression in vivo. To this end, we inoculated
orogastrically 8- to 10-week old CD-1 male mice with
a suspension of EcN cells harboring plasmid PFU34-
sat (n = 2) or EcN cells harboring vector PFU34
(n = 2). Control mice (n = 2) were given PBS. Before
starting the experiment stools were collected to assess
the absence of Ap-resistant resident microbiota. Mice
were given water containing 2 g/l ampicillin ad libi-
tum 24 hours prior to inoculation and through the
experiment. Five days post-inoculation, fresh fecal
samples, as well as the mucus layer from ileon and
colon sections, were collected and processed for
quantification of bacteria by growth on LB-Ap plates.
Two colonies of each bacterial count were analyzed
by PCR with sat specific primers to confirm that the
estimated colonization rates corresponded to the in-
oculated bacteria. A drop of each fecal or mucosal
suspension was deposited on a slide and visualized by
fluorescence microscopy.
The level of colonization was similar for all inoculated
mice, around 1-2x109 CFU/g of stool and 3-5x109 CFU/g
of mucus in ileon and colon sections (see Additional file 2:
Table S1) whereas samples from non-inoculated mice gave
no bacterial counts on LB-Ap plates. Expression of GFP
was visualized only in samples collected from the two
mice colonized with EcN harbouring the fusion plasmid
pFU34-sat (Fig. 3a). These results indicated that EcN sat
is expressed in distinct niches in the mouse intestine.
Expression of chromosome-encoded Sat was analysed
by Western blot analysis of intestinal mucosa samples
collected from inoculated mice using anti-Sat antibodies.
Equivalent samples from non-inoculated mice were
processed in parallel as a control. The presence of a
107 kDa protein in colon and ileon samples from inocu-
lated mice confirmed sat expression during EcN intes-
tinal colonization (Fig. 3b).
Sat-mediated cytotoxic effects on undifferentiated
epithelial cells
The Sat protein secreted by UPEC and DAEC strains ex-
erts cytotoxic effects on several epithelial cell lines. In-
ternalized Sat induces disruption of F-actin cytoskeleton,
Fig. 2 Serin protease activity of EcN Sat. a Concentrated culture supernatants (200 μg total protein) from the indicated E. coli strains were
incubated with 1 mM methoxysuccynil-Ala-Ala-Pro-Val p-nitroanilide at 37 °C for 18 h. Activity values, expressed as pmoles/μg protein at18 h,
were the mean ± SE of three independent assays. Asterisks indicate values significantly different from that of the knockout mutant EcNsat::cm (*P
< 0.05; **P = 0.000). Expression of Sat analysed by Western blot in each culture supernatant is shown in the upper panel. b Spectrin degradation
by EcN Sat. Spectrin (4 μg) was incubated with the indicated culture supernatants or left untretaed. Reaction products were separated by SDS-
6 % PAGE and stained by Commassie Blue. M, molecular mass marker
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vacuolization and cell death in non-polarized epithelial
cells [22], but these effects are not observed in fully differ-
entiated Caco-2 cells [23]. As EcN Sat is an active protease
we sought to examine whether the protein encoded in this
probiotic strain could induce cytotoxicity in sub-confluent
HeLa cells. To avoid cross-effects of other putative
SPATEs encoded in the EcN genome like Vat [12], cell-
free supernatants of strain HB101 expressing EcN Sat
were used for this study. A decrease of cell viability, mea-
sured by the MTT assay, was observed in HeLa cells from
8 h-treatment with Sat-containing concentrated culture
supernatants (see Additional file 3: Figure S2).
Effect of EcN Sat on paracellular permeability of Caco-2
cell monolayers
To test whether Sat from the probiotic strain EcN affects
the intestinal epithelial barrier, paracellular permeability
of polarized Caco-2 cells was measured using 3H-manni-
tol as a marker at 3 h post-infection with wild-type EcN
and the recombinant strains HB101 and EcNsat::cat ex-
pressing Sat from plasmid pSat, or expressing the in-
active Sat-S256I protein (Fig. 4a). We assessed that both
recombinants strains (HB101 and EcNsat::cat) displayed
equal growth rates in the culture medium DMEM. Incu-
bations with the corresponding concentrated cell-free
supernatants were performed in parallel (Fig. 4b). A sig-
nificant increase in the paracellular passage of mannitol
from apical to basolateral compartment was observed
only in Caco-2 monolayers incubated with samples of
HB101 bearing plasmid pSat (either bacterial suspen-
sions or concentrated cell-free supernatants). Expression
of the inactive Sat-S256I variant in this strain did not
affect paracellular permeability, which indicates that ac-
tivity of EcN Sat on the barrier integrity depends on its
Fig. 3 Analysis of Sat expression during EcN colonization of mouse intestine. a In vivo expression of the promoter fusion sat-gfpmut3.1 in samples
derived from the intestine of mice colonized with EcN harbouring pFU34-sat, or pFU34 as a control. Doses of 2x105 bacteria of the indicated
strains were used to inoculate orogastrically CD-1 mice (eight- to ten-weeks old), which were provided with drinking water containing ampicillin
from 48 hours prior to inoculation and over the entire course of the experiment. Five days post-inoculation fresh stool samples, as well as the
mucus layer from the ileon and colon sections, were collected. A drop of each fecal or mucosal suspension was deposited on a slide and visual-
ized by fluorescence microscopy. Representative images derived from one mouse of each type are shown. b Western blot analysis of EcN Sat ad-
hered to intestinal mucus of colonized mice. Ileon and colon mucus collected from inoculated mice were homogenized and proteins
precipitated with TCA. Equivalent samples collected from non-inoculated mice were processed in parallel for control. Cell-free supernatants (SN)
from EcN cultures grown in LB were used as a positive immunoblotting control
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proteolytic activity. These results are in accordance with
those described for the Sat protein from DAEC strains
[23] and suggest that the Sat protein encoded by pro-
biotic strains may also induce disassembly of tight junc-
tion proteins. However, expression of comparable EcN
Sat levels in the same probiotic background (strain EcN-
sat::cat bearing pSat) did not affect the paracellular per-
meability to 3H-mannitol (Fig. 4). It is known that EcN
positively modulates the epithelial barrier function by
promoting the formation of tight junctions [5–7]. There-
fore, other factors secreted by this probiotic strain may
counteract the negative effect of Sat on tight junctions-
associated proteins. To test this hypothesis Caco-2
monolayers were incubated either with bacterial suspen-
sions or concentrated culture supernatants of strain
HB101(pSat) in the presence of cell-free supernatants
collected from the probiotic strain. In both cases, super-
natants from the probiotic strain confer protection
against the Sat effect on paracellular permeability to
mannitol (Fig. 4). Cell free supernatants obtained from
the mutant strain EcNsat::cat produced the same pro-
tective effect (not shown).
It has been described that the TcpC protein of EcN
promotes upregulation of claudin-14 in HT-29/B6 cells,
resulting in increased TER and reduced paracellular per-
meability to mannitol [7]. Other studies aimed at deci-
phering the mechanism by which EcN restores barrier
integrity after enteropathogenic E. coli (EPEC) damage
revealed that this probiotic strain induces ZO-2 expres-
sion and its redistribution to the cell membrane in po-
larized T84 cells. In this case the bacterial factor
responsible for this effect was not identified [6]. Impair-
ment of Sat-mediated damage of Caco-2 cell barrier by
concentrated EcN culture supernatants (Fig. 4) indicated
that the protective effect could be attributed to a se-
creted factor. Thus, we sought to evaluate the ability of
EcN supernatants to prevent barrier disruption by EPEC
in polarized Caco-2 cell monolayers. The reduction in
TER caused by EPEC after 2 h-incubation was almost
completely abolished when infection was performed in
the presence of concentrated EcN supernatants (Fig. 5a).
In addition, the EPEC- deleterious effect on paracellular
permeability to mannitol was reduced by 70 % in the
presence of EcN supernatant (Fig. 5b).
Overall these results indicate that EcN Sat is able to
alter the paracellular permeability of Caco-2 cell mono-
layers. However, other factors secreted by the probiotic
strain prevent barrier disruption caused by pathogen-
related factors.
Effect of EcN Sat on gut colonization in mice
Some serine proteases of the SPATE family such as Pic
[35] or SigA [40] contribute to intestinal colonization in
animal models. In pathogenic E. coli strains, the corre-
sponding knockout mutants displayed reduced
colonization levels when compared to the wild- type
strain. In contrast, other proteases of this family like
SepA are not required for intestinal colonization [40].
To examine whether Sat has a role in gut colonization,
the streptomycin-treated mouse model was used to
compare the colonization capacity of the Sat deficient
mutant versus the wild-type strain. Mice were inoculated
with strain EcN Smr Rfr (sat wild-type group) or with
EcNsat::cat Smr Rfr Cmr (sat mutant group). No signifi-
cant differences in stool bacterial counts were observed
Fig. 4 Effect of EcN Sat on the paracellular permeability to 3H-
mannitol in Caco-2 cell monolayers. Paracellular passage of [3H]-D-
mannitol from apical to basolateral compartments of Caco-2 mono-
layers after 3-h incubation with suspensions of the indicated bacteria
(MOI 100) (a) or with the corresponding concentrated culture super-
natants (200 μg) (b). Equivalent amounts of recombinant Sat were
assessed by Western blot. The last bar of each panel corresponds to
cells incubated with the recombinant HB101(pSat) samples in the
presence of EcN culture supernatant (indicated as EcNSN added).
Data are presented as the percentage of tracer recovery relative to
the total tracer used. Values were corrected subtracting the recovery
of control cells incubated with the medium. Asterisks indicate values
significantly different from that of EcNsat::cm (*P < 0.05; ** < 0.01)
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between the two groups through the experiment. For
both strains colonization levels were between 108 to
109 CFU/g of stool (Fig. 6a). Quantification of adhered
bacteria to mucus samples collected from ileon and
colon on the last day of the experiment also yielded no
significant differences between these strains when tested
independently (Fig. 6a, right panel). These results sug-
gested that Sat is not required for EcN colonization of
the mouse intestine. They are in accordance with results
obtained with UPEC strains in murine models of ascend-
ing urinary tract infections, in which the sat mutant col-
onized bladder and kidneys to the same extent as the
wild type strain [18].
To better assess the contribution of Sat to intestinal
colonization we approached competition experiments
between the specific sat mutant and the wild-type strain.
This approach is more sensitive for the evaluation of the
colonization efficiency in streptomycin-treated mice
[35]. Mice were given simultaneously 1x105 CFU of each
strain (co-infection group), and bacteria in stools were
counted for 18 days. Results showed that wild type EcN
was outcompeted by the sat mutant strain (Fig. 6b). The
values of CFU/g stool were similar for both strains
within the first several days (around 5x108 CFU/g of
stool) but significant differences were observed around
day 10. After this time, colonization by wild-type EcN
fell to 107 CFU/g stool at day 18. At the end of the ex-
periment, bacterial counts in stools yielded percentages
of 70 % for the mutant strain EcNsat::cat versus 30 %
for the wild-type EcN. At day 18, quantification of ad-
hered bacteria to the intestinal mucus layer also showed
a higher proportion of the Sat deficient strain (70–80 %
versus 20-30 % of the wild type strain).
Recently, an in vivo study performed with Citrobacter
rodentium assigned to a class I SPATE protein (Crc1) a
putative role in immunomodulation by controlling
leukocyte infiltration and proinflammatory cytokines
levels in mouse intestine [41]. Moreover, some class II
SPATE proteins, like Pic and Tsh, cleave leukocyte sur-
face glycoproteins causing diverse effects in leukocyte
activation, migration and signalling [42]. A proteomic
analysis aimed at identifying potential host targets of Sat
from UPEC revealed a protein in the kidney membrane
that is similar to the leukocyte function associated mol-
ecule 1 (LFA-1) [20]. LFA-1 is a member of the β2-
integrin family of cell surface receptors. This protein is a
multifunctional adhesion molecule involved in various
interactions in the immune system being involved in
leukocyte migration [43]. Since lymphocyte migration to
the gut is required for immune homoeostasis, we sought
to analyse whether surface associated LFA-1 in leuko-
cytes could be degraded by EcN Sat. To this end we per-
formed flow cytometry analyses of human PBMCs
treated for 3 h with supernatants of strains EcNsat::cat,
EcNsat::cat bearing plasmid pSat, HB101, and HB101
bearing either plasmid pSat or pSat-S256I. Labelling with
anti-LFA-1 (anti CD-11/CD-18) antibodies that
recognize the native protein followed by Alexa Fluor 488
goat anti-mouse IgG did not show any significant differ-
ence between samples. These results indicated that
leukocyte-associated LFA-1 is not a target of EcN Sat.
Therefore the ability of the sat mutant strain to outcom-
pete EcN in the intestinal tract cannot be attributed to a
Sat effect on gut immune function mediated by LFA-1.
At present we cannot explain why the sat mutant out-
competes wild type EcN in the streptomycin-treated
Fig. 5 EcN culture supernatants impair EPEC-mediated effects on epithelial cell barrier. Caco-2 monolayers grown on Transwell filters were incu-
bated with EPEC alone (MOI 50) or with EPEC (MOI 50) in the presence of EcN cell-free culture supernatant (200 μg total protein). Incubation of
Caco-2 cells with EcN supernatants (ECSN) were performed in parallel as a control. a TER values before (black bars) and after 2 hours incubation
(white bars) were presented. b Paracellular passage of [3H]-D-mannitol from apical to basolateral compartments of Caco-2 monolayers after 2-h in-
cubation. Data are expressed as the percentage of tracer recovery relative to the total tracer used (*P < 0.05;)
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mouse model. Since growth rates of both strains in in
vitro cultures are indistinguishable, this fact could be as-
sociated to a better performance of the sat mutant in
the mouse intestine. In this sense, it has been described
that mutations in envZ, which result in reduced expres-
sion of some outer membrane proteins, render EcN a
better colonizer than the wild type EcN [44]. As EcN re-
sides associated with other members of the microbiota
in the mouse intestine, authors hypothesize that surface
differences between the envZ mutant and wild-type EcN
could result in different binding affinities for mixed bio-
films, allowing the mutant strain to colonize niches than
the wild-type strain cannot do. These mutants display
reduced levels of specific porins, being more resistant to
colicin and bile salts. In this context, the outer mem-
brane of the sat mutant lacks the autotransporter β-
barrel domain, which presents a porin structure. We
may speculate that this difference in bacterial surface
may modify interactions with other microbiota members
and/or the sensitivity to antimicrobial products released
by other intestinal strains.
Prevalence of the sat gene in natural E. coli intestinal
isolates
Epidemiological studies have shown a high prevalence of
the sat gene in E. coli strains associated with urinary
tract infections [18, 23]. Concerning strains causing in-
testinal infection, sat was detected in 46 % of 35 Afa/Dr
DAEC strains isolated from diarrhoeagenic samples [23].
Similarly, a study aimed at evaluating the prevalence of
several cytotoxins of the SPATE family in enteroaggrega-
tive E. coli (EAEC) isolates showed high frequency of the
Fig. 6 Colonization of the mouse intestine by EcN and EcNsat::cat. a Two sets of four mice were fed independently with 2x105 CFU of strain EcN
Smr Rfr (squares) or the mutant strain EcNsat::cat Smr Rfr Cmr (triangles). b Competition experiments: One set of four mice were fed with 2x105
CFU of a mixture (1:1) of strains EcN Smr Rfr (squares) and the mutant strain EcNsat::cat Smr Rfr Cmr (triangles). Three independent biological
assays were performed for these competition experiments (total n = 12). At the indicated times, stool samples were collected and processed for
bacterial counting. Results are expressed as Log10 CFU/g stool (left panels). At day 18, mice were sacrificed and sections from ileum and colon
were removed from each mouse. The mucus layer from each fragment was scraped, homogenized and processed for bacterial quantification.
Results, expressed as CFUx104/g of mucus, were the mean ± SE of the three independent biological assays (right panels). Asterisks indicate values
significantly different from that of the parental strain EcN (*p < 0.05, **p = 0.000)
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sat gene in this group (74.5 % of 55 strains analysed).
However, this study also revealed the absence of sat in
all the enterotoxigenic E. coli (ETEC), EPEC or enteroin-
vasive E. coli (EIEC) isolates analysed in parallel (10
strains of each group) [45]. In order to assess the preva-
lence of sat among natural E. coli intestinal isolates we
performed a PCR survey. For this study we selected 29
E. coli strains of the ECOR collection [46] recovered
from stools of healthy individuals. The strains were ex-
amined by PCR using specific primers that allow amplifi-
cation of the DNA sequence encoding Sat. This
screening showed ten positive isolates that yielded the
expected sat amplification fragment (34.8 %). Accuracy
of the PCR product was verified by nucleotide sequen-
cing. Distribution of these ten sat positive isolates
among the E. coli phylogenetic groups revealed a high
prevalence of strains belonging to phylogenetic groups
associated with virulent strains that cause extra-
intestinal infections (80 %), namely group D (6 isolates)
and group B2 (2 isolates) (Table 2). Only one intestinal
isolate fits into the phylogenetic group A generally asso-
ciated with non-pathogenic E. coli strains [47]. Expres-
sion of sat in these strains was evaluated by
immunodetection of the secreted protein with specific
antibodies against the passenger domain of Sat. All the
intestinal isolates with the sat gene yielded a cross-
reactive protein band in the Western blot analysis.
The Sat protein from the probiotic EcN differs in eight
residues with respect to the UPEC protein, whereas only
three changes that fit into the non-conservative category
(N352D, N729D and D894N) were observed when com-
pared to the protein from DAEC strains (see Additional
file 2: Table S2). Interestingly, among the commensal sat
positive strains identified in this study, only EcoR56 dis-
played the same amino acid sequence as the Sat protein
from pathogenic DAEC (D352, D729 and N894). The
other strains expressed a Sat protein with N352, N729
and D894 residues as EcN Sat or with only one conser-
vative change (N729S) (Table 2).
The presence of multiple virulence factors in the pro-
biotic strain EcN raises the question as to why this strain
does not cause symptomatic infections. Several possibil-
ities have been proposed [12]. First, virulence genes may
be inactivated in probiotic or commensal strains. On the
other hand, some of these genes may encode factors that
increase overall fitness during colonization of the human
gut. As stated above, the distinction between virulence
and fitness factors is not always clear. In addition, the
role of a given virulence factor in pathogenesis may de-
pend on the genetic background of the strain. In this
sense, TcpC protein that is expressed by the probiotic
strain EcN has been shown to contribute to UPEC viru-
lence. This protein, with high prevalence in Gram-
negative pathogens, contains a Toll/IL-1 receptor (TIR)
-binding domain. In pathogens, TcpC interacts with
Myd88 and inhibits TLR signalling and downstream
pathways. By this mechanism, TcpC impairs innate im-
munity causing inflammation and tissue damage [48,
49]. However, in strain EcN, which displays anti-
inflammatory and immunomodulatory effects, TcpC was
shown to improve the intestinal barrier through upregu-
lation of the tight junction-protein claudin-14 [7].
Conclusions
Sat is one of the proteins with cytotoxic activity encoded
in the EcN genome. Here we show that EcN Sat is a
functional protease that is expressed in the mouse intes-
tinal tract. Our results, together with other reports, indi-
cate that both Sat function and Sat cytotoxicity may rely
on other host- and bacterial factors. Regarding host fac-
tors, it should to be stressed that Sat cytotoxic effects
depend on the cellular line and the differentiation state.
Sat-mediated disruption of actin cytoskeleton, vacuoliza-
tion and cell detachment were not observed in mono-
layers of polarized Caco-2 cells, a model that mimics
intestinal epithelium and barrier. It has been suggested
that putative regulatory mechanisms may operate in po-
larized epithelia, which may impair Sat access or action
on target intracellular proteins [23]. Considering the
strain background, our results show that Sat-mediated
increase in paracellular permeability of Caco-2 mono-
layers is impaired by other secreted factors encoded in
the probiotic strain EcN. Thus, the role of Sat in
Table 2 Characteristics of the sat positive strains from the ECOR
collection isolated from stools of healthy humansa
Sat amino acid residue at position
Strain Serotype Group 352 729 894
CFT073b O6:K2:H1 B2 D D N
IH11128b O75:K5:H− B2 D D N
EcNb O6:K5:H1 B2 N N D
ECOR24 O15:NM A N N D
ECOR35 O1:NM D N N D
ECOR36 O79:H25 D N N D
ECOR38 O7:NM D N N D
ECOR39 O7:NM D N S D
ECOR41 O7:NM D N S D
ECOR43 ONT:HNT E N S D
ECOR49 O2:NM D N N D
ECOR51 O25:N B2 N N D
ECOR56 O6:H1 B2 D D N
a Analyzed strains that did not yield sat amplification in the PCR screening:
ECOR strains 1, 2, 4, 5, 6, 8, 9, 10, 12, 13, 15, 26, 28, 42, 53, 54, 56, 59, 61
and 63
b Strains CFT073 (UPEC), IH11128 (Afa/Dr DAEC) and EcN were included
for comparison
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intestinal pathogenesis relies on the pattern of genetic
determinants responsible for the bacterial pathotype. Ex-
pression of particular virulence factors may help Sat to
meet specific intracellular target substrates.
At present the role of Sat in the probiotic strain re-
mains elusive. Although Sat contributes to pathogenicity
in the urine tract, the prevalence of sat in E. coli strains
isolated from intestinal microbiota of healthy individuals
suggests that Sat may not act as a virulence factor in the
human gut. This hypothesis is in accordance with the
very low prevalence of sat among several E. coli entero-
pathogenic groups (ETEC, EIEC, EPEC). The high
prevalence of sat in intestinal E. coli strains of group D
suggests that the presence of this gene may be advanta-
geous for pathogenesis in extra-intestinal environments.
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